Allena Pharmaceuticals Inc. (ALNA): Investing has never been easier – Invest Chronicle

Allena Pharmaceuticals Inc. (ALNA): Investing has never been easier

At the end of the latest market close, Allena Pharmaceuticals Inc. (ALNA) was valued at $0.12. In that particular session, Stock kicked-off at the price of $0.1201 while reaching the peak value of $0.1262 and lowest value recorded on the day was $0.116. The stock current value is $0.12.Recently in News on May 4, 2022, Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that it has entered into a securities purchase agreement with an investor for the issuance and sale of an aggregate of 1,436.0688 shares of its Series D Convertible Preferred Stock, and 1,436.0688 shares of its Series E Convertible Preferred Stock in a registered direct offering for an aggregate gross proceeds of approximately $2.8 million, before deducting placement agent fees and other offering expenses. The shares of Series D Convertible Preferred Stock and Series E Convertible Preferred Stock each have a stated value of $1,000 per share and are convertible into an aggregate of 8,975,430 shares of common stock of the Company upon the conversion of the Series D Convertible Preferred Stock and into an aggregate of 8,975,430 shares of common stock of the Company upon the conversion of the Series E Convertible Preferred Stock, in each case, at a conversion price of $0.16 per share. You can read further details here

Allena Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.7720 on 01/04/22, with the lowest value was $0.0683 for the same time period, recorded on 05/11/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Allena Pharmaceuticals Inc. (ALNA) full year performance was -90.82%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Allena Pharmaceuticals Inc. shares are logging -91.45% during the 52-week period from high price, and 81.55% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.07 and $1.45.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1744912 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Allena Pharmaceuticals Inc. (ALNA) recorded performance in the market was -80.32%, having the revenues showcasing -57.60% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.24M, as it employees total of 21 workers.

Market experts do have their say about Allena Pharmaceuticals Inc. (ALNA)

During the last month, 0 analysts gave the Allena Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2617, with a change in the price was noted -0.22. In a similar fashion, Allena Pharmaceuticals Inc. posted a movement of -64.21% for the period of last 100 days, recording 7,194,599 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALNA is recording 0.42 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Allena Pharmaceuticals Inc. (ALNA)

Raw Stochastic average of Allena Pharmaceuticals Inc. in the period of last 50 days is set at 28.09%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.12%. In the last 20 days, the company’s Stochastic %K was 22.12% and its Stochastic %D was recorded 21.55%.

Bearing in mind the latest performance of Allena Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -80.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -84.06%, alongside a downfall of -90.82% for the period of the last 12 months. The shares increased approximately by -10.24% in the 7-day charts and went down by -5.97% in the period of the last 30 days. Common stock shares were lifted by -57.60% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]